Strategic Manufacturer Partner As a long standing contract manufacturer with a controlling stake by Hypera S.A., Brainfarma has the capacity and track record to expand manufacturing for Hypera brands and the Neo Química generics portfolio. Opportunities include private label production, scaling existing formulations like Doralgina, Gastrol, Histamin and Massageol, and co development of new generic SKUs for the Brazilian and regional markets.

Regional Manufacturing Hub Brainfarma's Anápolis plant is a major Latin American facility enabling nearshore supply to Brazil and neighboring markets. This positions the company to support regional expansion, reduce lead times, and optimize logistics for Hypera and other distributors seeking reliable high volume production in the Latin American region.

Regulatory Readiness With registrations for traditional medicines and generics already in place, Brainfarma can accelerate market entry for new products through ready to scale manufacturing capabilities and established regulatory familiarity, reducing development risk and time to launch for partners.

Diversification Potential Revenue and scale combined with a strong buyer relationship suggest opportunities to diversify revenue through additional contract manufacturing work, packaging, serialization, and supply chain services for other regional clients, lowering concentration risk and improving margins.

Competitive Advantage Brainfarma's large Latin American production footprint, proximity to Hypera, and a broad portfolio of established products create a compelling value proposition for high volume contracts, offering cost efficiency and reliable supply to regional players seeking scale.